type here...

CATEGORIES

Diagnostics

LATEST

123...7Page 1 of 7

TRENDING

EDITORS CHOICE

AURA™ adds Protein/Non Protein Identification to Horizon®

Medika Life -
Aura revolutionizes biologic stability analysis, enabling simple protein and non-protein aggregate identification in formulation development and analytical testing

BRCA1 and 2: The Breast Cancer Genes

Dr Jeff Livingston -
Recent breast cancer statistics suggest that 1 in 8 women will be diagnosed with breast cancer in their lifetime. Approximately 60 percent of women who have inherited these harmful gene mutations will develop breast cancer.

Coronavirus: FDA Authorizes First Point-of-Care Antibody Test

Medika Life -
The Assure COVID-19 IgG/IgM Rapid Test Device is currently the only FDA authorized COVID-19 POC serology test and is available by prescription only.

Will Blood Glucose Become The New Blood Pressure?

John Nosta -
The utility of simple and watched-based measurements can put blood glucose on everyone’s radar.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories